---
$id: https://graph.org.ai/products/commodity/51181924
$type: Product
source: UNSPSC
code: "51181924"
title: "Panomifene"
class: "51181900"
classTitle: "Gonadotropic hormones and ovarian stimulants and inhibitors"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Panomifene

**UNSPSC Code**: 51181924
**Class**: [Gonadotropic hormones and ovarian stimulants and inhibitors](Gonadotropic hormones and ovarian stimulants and inhibitors.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiestrogen with the molecular formula C25H24F3NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GCW5E728OC, chemically known as ethanol, 2-((2-(4-(3,3,3-trifluoro-1,2-diphenyl-1-propenyl)phenoxy)ethyl)amino)-, (e)- but generally known as panomifene, which bears US NIH Compound Identifier 3033654. European Medicines Agency schedules Panomifene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09606MIG. The term PANOMIFENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 2, No. 3, 1988, List 28). PANOMIFENE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule panomifene under HS 29221980 and SITC 51461. As of Q4 2014, PANOMIFENE remains the US FDA Preferred Term for this commodity. Panomifene bears US NLM identifiers UMLS ID C0244902 and NCI Concept Code C66304. SMILES: FC(F)(F)C(=C(\C1CCC(OCCNCCO)CC1)C1CCCCC1)\C1CCCCC1.

